NCT00119769 - The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

July 31, 2008

Conditions

HIV InfectionsLipodystrophy

Interventions

DRUG

Placebo

Placebo, 0.7 mg/day injected subcutaneously

DRUG

Genotropin (human recombinant Growth hormone)

Genotropin, 0.7 mg/day injected subcutaneously

Trial Locations (1)

Clinical Research Unit, Hvidovre University Hospital, Hvidovre